Systemic Administration of Abeta mAb Reduces Retinal Deposition of Abeta and Activated Complement C3 in Age-Related Macular Degeneration Mouse Model
Open Access
- 14 June 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (6), e65518
- https://doi.org/10.1371/journal.pone.0065518
Abstract
Age-related macular degeneration (AMD) is a leading cause of legal blindness in the Western world. There are effective treatments for the vascular complications of neo-vascular AMD, but no effective therapies are available for the dry/atrophic form of the disease. A previously described transgenic CFH-gene deficient mouse model, (cfh−/−), shows hallmarks of early AMD. The ocular phenotype has been further analysed to demonstrate amyloid beta (Aβ) rich basement membrane deposits associated with activated complement C3. Cfh−/− mice were treated systemically in both prophylactic and therapeutic regimes with an anti-Aβ monoclonal antibody (mAb), 6F6, to determine the effect on the cfh−/− retinal phenotype. Prophylactic treatment with 6F6 demonstrated a dose dependent reduction in the accumulation of both Aβ and activated C3 deposition. A similar reduction in the retinal endpoints could be seen after therapeutic treatment. Serum Aβ levels after systemic administration of 6F6 show accumulation of Aβ in the periphery suggestive of a peripheral sink mechanism. In summary, anti-Aβ mAb treatment can partially prevent or reverse ocular phenotypes of the cfh−/− mouse. The data support this therapeutic approach in humans potentially modulating two key elements in the pathogenesis of AMD – Aβ and activated, complement C3.Keywords
This publication has 44 references indexed in Scilit:
- Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degenerationProceedings of the National Academy of Sciences of the United States of America, 2011
- Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse modelNeuroImage, 2011
- Viewing Ageing Eyes: Diverse Sites of Amyloid Beta Accumulation in the Ageing Mouse Retina and the Up-Regulation of MacrophagesPLOS ONE, 2010
- Soluble and Mature Amyloid Fibrils in Drusen DepositsInvestigative Ophthalmology & Visual Science, 2010
- Amyloid-Peptide Vaccinations Reduce β-Amyloid Plaques but Exacerbate Vascular Deposition and Inflammation in the Retina of Alzheimer’s Transgenic MiceThe American Journal of Pathology, 2009
- Complement Factor H Is Critical in the Maintenance of Retinal PerfusionThe American Journal of Pathology, 2009
- Early Age-Related Macular Degeneration, Cognitive Function, and DementiaJAMA Ophthalmology, 2009
- Targeting age-related macular degeneration with Alzheimer’s disease based immunotherapies: Anti-amyloid-β antibody attenuates pathologies in an age-related macular degeneration mouse modelVision Research, 2008
- Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunctionProceedings of the National Academy of Sciences of the United States of America, 2007
- CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degenerationJCI Insight, 2007